Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.

RTSL - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.92K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rapid Therapeutic Science Laboratories, Inc.Rapid Therapeutic Science Laboratories, Inc.0--21%--1.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1,919.00
Enterprise Value$3.45 Million
Earnings per Share$-0.01
Beta-2.03
Outstanding Shares19,188,000

Return

Return on Equity-20.57%ROE
Return on Assets65.57%
Return on Invested Capital3.29%

Valuation & Multiples

P/E Ratio-0.03P/E Ratio
PEG0.02PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-33.97
Enterprise Value to Net Income5
Total Debt to Enterprise1
Debt to Equity-1.12Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Rapid Therapeutic Science Laboratories, Inc.

3 employees
CEO: Donal R. Schmidt Jr.

Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various co...